Study abroad options expand for honor students

By on June 13, 2021

first_img Previous articleLate goal ties No. 7 Texas in AustinNext articleREC center offers fall break trip to Palo Duro Canyon Alexa Hines RELATED ARTICLESMORE FROM AUTHOR Breaking barriers: Trailblazing women in sports media Facebook Three honors students hold a TCU flag while studying abroad in Dublin, Ireland earlier in 2017. Alexa is the Audience Engagement Editor for TCU360. She is a journalism major and Spanish minor from Orange County, California. In her free time, Alexa loves reading about and watching sports. ReddIt TCU places second in the National Student Advertising Competition, the highest in school history Alexa Hines Alexa Hineshttps://www.tcu360.com/author/alexa-hines/ Alexa Hineshttps://www.tcu360.com/author/alexa-hines/ Alexa Hineshttps://www.tcu360.com/author/alexa-hines/ Snow sees the importance and value in studying abroad but realizes some programs and majors here at TCU hinder a student’s ability to explore and experience new places.“One of my major goals as dean of the John V. Roach Honors College is to provide high-impact practices that catapult learning to a new height – one of those practices is education abroad,” Snow said. “I hope to be able to claim someday that 100 percent of our honors students have had significant exposure to new cultures and have developed a broader worldview.” Junior psychology major Hope Bentley studied abroad in Scandinavia in summer 2017. One of the best parts about studying abroad for her is the other students she met.“I made really great friends, and we became a kind of close you can only get by spending weeks in a foreign country together,” Bentley said. “The value in studying abroad for students is getting to see how other people live life. It exposes you to a different way of thinking and forces you out of your comfort zone.”There are many programs offered outside of the honors explorations program. TCU has flagship programs in five different cities, but many approved programs in other countries. All the programs are run through the Center for International Studies.“It is difficult to summarize in just a few words the benefits of studying abroad – we know from our past students that it provides an incredible opportunity for both personal and professional growth,” Dr. Sandra Callaghan, director of the Center for International Studies said. “Studying abroad challenges students to think deeply about who they are as a global citizen. We hear from students who have studied abroad that they were pushed to consider their own values and cultural biases.”Snow said studying abroad can help students achieve the mission statement of TCU.“While one can learn from teachers and texts, the best way to learn to become a ‘responsible citizen in a global community’ is to place oneself in the actual environment and see the world through the lenses of the people,” Snow said. ReddIt printGet out of the bubble.That is Dr. Diane Snow’s, dean of the John V. Roach Honors College, goal for students. She wants to see more students in and outside of the honors college study abroad. Snow, along with other faculty members, are implementing more options for honors students to study abroad.“We are trying to put together a wide variety and selection of academic experiences that involve going abroad or going to new places,” Snow said. “We are developing up a buffet or smorgasbord or a wide selection and they will all be under the guise of honors abroad, even if they are not over the ocean.”These options include two new programs Snow is planning, to Washington D.C. and England.While Washington D.C. is not over an ocean, Snow said it can still provide a different experience for students. The program will run for a month over the summer and will focus on how our capital works.“There will be four faculty members from TCU, each teaching one week for a four-week program,” Snow said. “Given our political climate right now, I think it is really important for students to understand how politics work, how government works, how persuasion works, how do things get done and not done in Congress for example.”Snow is also bringing over a program from her previous institution, the University of Kentucky, called “Where Are All the Women?” The program first started as a domestic course looking at the attrition of women in STEM fields and sciences.“Every time we had a discussion someone would say, ‘Is it only like this in the U.S. or is it like this all over the world?’ as we were learning statistics, patterns and things,” Snow said. “Finally I just said this question comes up so much, why don’t we turn this into a European course and find out.”Last time Snow taught the course, the program had all kinds of guests and visitors for the students.  The guest speakers were there for the students to interact with and talk to.“We had lots of exposure to what it is like there,” Snow said. “The students had to do interviews and pick one particular thing about this dilemma that they were interested in, do a presentation on it and then the final is to commit to one thing they would do to make the world a better place for women in science. They were all very creative and had to all be different.”Snow is also keeping the three study abroad programs already in the John V. Roach Honors College: Cultural Routes, Cultural Pathways and Cultural Pilgrimages.Cultural Routes is a program run by Dr. Ron Pitcock for the past 10 years. Snow explains it as a “tried and true” study abroad program. In the summer of 2017, Pitcock took first-year honors students to Germany, Switzerland and Italy. “Dr. Pitcock has put together a really deep and meaningful experience for students to engage in the culture in each of those countries,” Snow said.  “I am very happy with that course.”Cultural Pathways is run by Dr. Beata Jones. In the summer of 2017, Jones and honors students went to Poland, Hungary and the Czech Republic.The Cultural Pilgrimages program takes a look at Europe from a different point of view. Students, led by Dr. Elizabeth Flowers and Dr. Darren Middleton, take a look at why various groups of people make pilgrimages. In the summer of 2016, the group went to Dublin, Republic of Ireland, Belfast, Northern Ireland and London, England.center_img World Oceans Day shines spotlight on marine plastic pollution Twitter Linkedin Alexa Hineshttps://www.tcu360.com/author/alexa-hines/ Tunnel of Oppression highlights different groups, encourages change Linkedin Twitter + posts Alumnus to reopen local bar Welcome TCU Class of 2025 Facebook Seniors react to postponing May Commencementlast_img read more

Continue Reading


Global Oncology Partnering Directory 2015-2020: Updated with the Latest Deal Trends, Players and Financials…

By on June 2, 2021

first_img WhatsApp Global Oncology Partnering Directory 2015-2020: Updated with the Latest Deal Trends, Players and Financials – ResearchAndMarkets.com TAGS  Previous articleJohn Sarkis Joins Align as Chief Revenue OfficerNext articleFA rescinds 1 of Southampton’s red cards in 9-0 loss Digital AIM Web Support Twitter Pinterest DUBLIN–(BUSINESS WIRE)–Feb 4, 2021– The “Global Oncology Partnering 2015-2020: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. The Global Oncology Partnering 2015-2020: Deal trends, players and financials report provides an understanding and access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter oncology partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors oncology technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element. The report takes readers through the comprehensive Oncology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Oncology deals. The report presents financial deal terms values for Oncology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals. In addition, a comprehensive appendix is provided with each report of all Oncology partnering deals signed and announced since 2015. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Oncology technologies and products. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not. This report contains a comprehensive listing of all oncology partnering deals announced since 2015 including financial terms where available including over 4,000 links to online deal records of actual oncology partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. Report scope Global Oncology Partnering 2015-2020: Deal trends, players and financials is intended to provide the reader with an in-depth understanding and access to oncology trends and structure of deals entered into by leading companies worldwide. Global Oncology Partnering 2015-2020: Deal trends, players and financials includes:Trends in oncology dealmaking in the biopharma industry since 2015Analysis of oncology deal structureAccess to headline, upfront, milestone and royalty dataAccess to over 4,000 oncology deal recordsThe leading oncology deals by value since 2015 In Global Oncology Partnering 2015-2020: Deal trends, players and financials, the available deals are listed by:Company A-ZHeadline valueStage of development at signingDeal component typeSpecific therapy target Key Topics Covered: Executive Summary Chapter 1 – Introduction Chapter 2 – Trends in Oncology dealmaking 2.1. Introduction 2.2. Oncology partnering over the years 2.3. Oncology partnering by deal type 2.4. Oncology partnering by industry sector 2.5. Oncology partnering by stage of development 2.6. Oncology partnering by technology type 2.7. Oncology partnering by therapeutic indication Chapter 3 -Financial deal terms for Oncology partnering 3.1. Introduction 3.2. Disclosed financials terms for Oncology partnering 3.3. Oncology partnering headline values 3.4. Oncology deal upfront payments 3.5. Oncology deal milestone payments 3.6. Oncology royalty rates Chapter 4 – Leading Oncology deals and dealmakers 4.1. Introduction 4.2. Most active in Oncology partnering 4.3. List of most active dealmakers in Oncology 4.4. Top Oncology deals by value Chapter 5 – Oncology contract document directory 5.1. Introduction 5.2. Oncology partnering deals where contract document available Chapter 6 – Oncology dealmaking by therapeutic target 6.1. Introduction 6.2. Deals by Oncology therapeutic target AppendicesAppendix 1 – Directory of Oncology deals by company A-Z since 2015Appendix 2 – Directory of Oncology deals by deal type since 2015Appendix 3 – Directory of Oncology deals by stage of development since 2015Appendix 4 – Directory of Oncology deals by technology type since 2015 For more information about this report visit https://www.researchandmarkets.com/r/ofadi1 View source version on businesswire.com:https://www.businesswire.com/news/home/20210204005813/en/ CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: HEALTH ONCOLOGY SOURCE: Research and Markets Copyright Business Wire 2021. PUB: 02/04/2021 11:08 AM/DISC: 02/04/2021 11:08 AM http://www.businesswire.com/news/home/20210204005813/en Local NewsBusinesscenter_img By Digital AIM Web Support – February 4, 2021 Twitter WhatsApp Pinterest Facebook Facebooklast_img read more

Continue Reading


Compliance: ‘Mailbox rule’ for TRID timing requirements

By on December 18, 2020

first_imgCUNA’s compliance staff receives a number of questions about the TILA-RESPA integrated disclosure (TRID) rule, leading to publication of a recent CompBlog post addressing means of delivery and timing requirements for the Loan Estimate and Closing Disclosure forms.The post summarizes the default rule of law for establishing the time the borrower is deemed to receive the disclosure.Under TRID, the lender is required:To deliver the loan estimate no later than the third business day after the lender receives the consumer’s application for a mortgage loan; andTo ensure the consumer receives the closing disclosure no later than 3 business days before consummation of the loan. Consummation is the moment the borrower becomes contractually obligated on the loan, after signing the loan documents.Regulation Z provides that if any required disclosures are not provided to the consumer in-person, then the consumer is considered to have received the disclosures 3 business days after they are delivered or placed in the mail (the “mailbox rule”). continue reading » 30SHARESShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblrlast_img read more

Continue Reading


PANCAP urged to become a leader in human rights

By on September 26, 2020

first_img Sharing is caring! NewsRegional PANCAP urged to become a leader in human rights by: – November 19, 2011 23 Views   no discussions Image via: topnews.usNASSAU, Bahamas — Member states of the Caribbean Community (CARICOM) have been called upon to revamp the Pan Caribbean Partnership against HIV and AIDS (PANCAP) by establishing the partnership as the Caribbean’s leader in promoting human rights and developing legislation to protect the rights of those persons living with and affected by HIV and AIDS. The call was made by Dr Antonie Gabriel Thimothé, Directeur Général, Minister of Public Health and Population of Haiti during his special presentation at the opening ceremony of the PANCAP’s 11th Annual General Meeting, which took place on Friday in The Bahamas under the theme “Enhancing Country Ownership and Sustainability.” “Stigma and discrimination can hinder efforts to fight the AIDS epidemic, the Ministry of Health of Haiti strongly supports the idea that countries in the region, through PANCAP, work together to address those issues by adopting a regional legislation that can enforce the rights of people living with HIV and facilitate their integration into society,” Thimothé said. He added that the contribution of PANCAP in parliamentarian advocacy, resource mobilization and promotion of universal access continues to be valuable. However, he noted that there was a need for CARICOM member states to adopt a more holistic approach, including economic, social and cultural to ensure ownership and sustainability of the national response to HIV and AIDS. Dr Hubert Minnis, Minister of Health of The Bahamas said harmonisation is critical to the new direction of the partnership and sustainability of its programmes. “We are still faced with a number of challenges. One such challenge is sustainability of current HIV and AIDS programmes within the Caribbean. All efforts must be made in the region to sustain HIV programmes in all aspects – in prevention, care and treatment. This will require the commitment of governments and people’s of the Caribbean,” he said. He explained that the primacy of prevention efforts could not be overemphasized and the region ran the risk of irrelevant and sub-optimal programming if it did not consistently and accurately characterise the epidemic, its drivers and trends. Minnis further added that in this time of reduced resources for HIV and AIDS, improved coordination and harmonisation of efforts had become even more important. “In these times of scarcity, we should seriously consider multi-sectoral involvement, strengthening health systems, integration of HIV interventions and decentralization of services into conventional and non-conventional settings. Equally important is the collection of strategic information coupled with monitoring and evaluation,” Minnis said. He urged PANCAP to concentrate on new developing strategies, strengthening existing successful ones and accelerating the pace of the Caribbean’s fight against the epidemic. Julius Timothy, Minister of Health of Dominica said the extent to which countries could create enabling environments, increase access by key populations and slow new HIV infections required the support, solidarity and the creative energies of PANCAP. He advised that in a time of economic recession, the Caribbean must ensure that it shaped international investments in the region’s own image to better own the outcomes. “National success says something about the region much like national shortcomings. We must therefore be prepared to support each other as countries,” Timothy said.Caribbean News Now Tweetcenter_img Share Share Sharelast_img read more

Continue Reading